...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pretty quiet on the Zenith front,

Its been very very quite on the Zenith front in terms of any financing PP news, is it still happening or has a better come up....   We have also heard very little on the science end from the ZEN 3694 trial , is this on purpose ... Something has got to give soon in terms of news

Share
New Message
Please login to post a reply